In vitro release of a water-soluble agent from low viscosity biodegradable, injectable oligomers

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 65, Issue 3, 2007, Pages 336-345

  Sharifpoor, Soroor ^a   Amsden, Brian ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Caprolactone; Biodegradable thermoplastic; Injectable; Local delivery; Osmotic release; Trimethylene carbonate; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; OLIGOMER; POLY(1,3 TRIMETHYLENE CARBONATE); POLY(EPSILON CAPROLACTONE CO 1,3 TRIMETHYLENE CARBONATE); TREHALOSE; UNCLASSIFIED DRUG;

ARTICLE; BIODEGRADABILITY; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; MOLECULAR WEIGHT; OSMOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; VISCOSITY;

CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DELAYED-ACTION PREPARATIONS; DIOXANES; DRUG CARRIERS; DRUG COMPOUNDING; EXCIPIENTS; FEASIBILITY STUDIES; FREEZE DRYING; HEXANOIC ACIDS; HYDROLYSIS; INJECTIONS; KINETICS; LACTONES; OSMOSIS; POLYMERS; SOLUBILITY; SOLVENTS; TECHNOLOGY, PHARMACEUTICAL; TREHALOSE; VISCOSITY; VITAMIN B 12; VITAMIN B COMPLEX; WATER;

EID: 33847320641     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2006.09.008     Document Type: Article

References (37)

1. Hatefi A., and Amsden B. Biodegradable injectable in situ forming drug delivery systems. J. Control. Release 80 (2002) 9-28
2. Senior J., and Radomsky M. Sustained-Release Injectable Products (2000), Interpharm Press
3. C.G. Pitt, A. Schindler, Biodegradation of polymers, in: S.D. Bruck (Ed.), Controlled Drug Delivery, 1983, pp. 53-80.
4. Bergsma J.E., Rozema F.R., Bos R.R.M., Boering G., Debruijn W.C., and Pennings A.J. In-vivo degradation and biocompatibility study of in-vitro pre-degraded as-polymerized polylactide particles. Biomaterials 16 4 (1995) 267
5. Bergsma J.E., Debruijn W.C., Rozema F.R., Bos R.R.M., and Boering G. Late degradation tissue-response to poly(l-lactide) bone plates and screws. Biomaterials 16 1 (1995) 25
6. R.S. Bezwada, Liquid copolymers of epsilon-caprolactone and lactide, US patent, 5442033 (1995).
7. A.G. Scopelianos, R.S. Bezwada, S.C. Arnold, Injectable liquid copolymers for soft tissue repair and augmentation, US patent, 5 824 333 (1998).
8. R.S. Bezwada, S.C. Arnold, Liquid absorbable copolymers for parenteral applications, US patent, 5 653 992 (1997).
9. A.G. Scopelianos, S.C. Arnold, R.S. Bezwada, M.B. Roller, S.T. Huxel, Injectable microdispersions for soft tissue repair and augmentation, US patent, 5,728,752 (1998).
10. Amsden B., Hatefi A., Knight D., and Bravo-Grimaldo E. Development of biodegradable injectable thermoplastic oligomers. Biomacromolecules 5 2 (2004) 637-642
11. Winternitz C.I., Jackson J.K., Oktaba A.M., and Burt H.M. Development of a polymeric surgical paste formulation for taxol. Pharm. Res. 13 3 (1996) 368-375
12. R. Berggren, D. Enscore, S. Marks, J. Osborne, P.-L. Wong, W. Roorda, Injectable drug delivery system and method, US patent, 5,620,700 (1997).
13. Brode G.L., and Koleske J.V. Lactone polymerization and polymer properties. J. Macromol. Sci. Chem. A 6 6 (1972) 1109-1144
14. Pitt C.G. Poly-ε-caprolactone and its copolymers. In: Chasin M., and Langer R. (Eds). Biodegradable Polymers As Drug Delivery Systems (1990), Marcel Dekker, New York 71-120
15. Zhu K.J., Hendren R.W., Jensen K., and Pitt C.G. Synthesis, properties, and biodegradation of poly(1,3-trimethylene carbonate). Macromolecules 24 (1991) 1736-1740
16. Pego A.P., Van Luyn M.J.A., Brouwer L.A., van Wachem P.B., Poot A.A., Grijpma D.W., and Feijen J. In vivo behavior of poly(1,3-trimethylene carbonate) and copolymers of 1,3-trimethylene carbonate with d,l-lactide or epsilon-caprolactone: degradation and tissue response. J. Biomed. Mater. Res. Part A 67A 3 (2003) 1044-1054
17. Acemoglu M. Chemistry of polymer biodegradation and implications on parenteral drug delivery. Int. J. Pharm. 277 1-2 (2004) 133-139
18. Fabre T., Schappacher M., Bareille R., Dupuy B., Soum A., Bertrand-Barat J., and Baquey C. Study of a (trimethylene carbonate-co-epsilon-caprolactone) polymer - Part 2: in vitro cytocompatibility analysis and in vivo ED1 cell response of a new nerve guide. Biomaterials 22 22 (2001) 2951
19. In't Veld P.J.A., Velner E.M., Van de Witte P., Hamhuis J., Dijkstra P.J., and Feijen J. Melt block copolymerization of ε-caprolactone and l-lactide. J. Polym. Sci. A Polym. Chem. 35 (1997) 219-226
20. Hiltunen K., Seppala J.V., and Harkonen M. Effect of catalyst and polymerization conditions on the preparation of low molecular weight lactic acid polymers. Macromolecules 30 3 (1997) 373-379
21. Crescenzi V., Manzini G., Calzolari G., and Borri C. Thermodynamics of fusion of poly-β-propiolactone and poly-ε-caprolactone. Comparative analysis of the melting of aliphatic polylactone and polyester chains. Eur. Polym. J. 8 (1972) 449-463
22. Gu F., Younes H.M., El-Kadi A.O., Neufeld R.J., and Amsden B.G. Sustained interferon-gamma delivery from a photocrosslinked biodegradable elastomer. J. Control. Release 102 3 (2005) 607-617
23. Rafler G. Biodegradable polymers.8. On the kinetics of ring-opening polymerization of 1,3-dioxane-2-one (trimethylene carbonate). Acta Polym. 44 3 (1993) 168-170
24. Albertsson A., and Eklund M. Synthesis of copolymers of 1,3-dioxan-2-one and oxepan-2-one using coordination catalysts. J. Polym. Sci. A Polym. Chem. 32 (1994) 265-279
25. Pego A.P., Poot A.A., Grijpma D.W., and Feijen J. In vitro degradation of trimethylene carbonate based (Co)polymers. Macromol. Biosci. 2 9 (2002) 411-419
26. Cai J., Zhu K.J., and Yang S.L. Surface biodegradable copolymers - poly(d,l-lactide-co-1-methyl-1,3-trimethylene carbonate) and poly(d,l-lactide-co-2,2-dimethyl-1,3-trimethylene carbonate): preparation, characterization and biodegradation characteristics in vivo. Polymer 39 18 (1998) 4409-4415
27. Siegel R., Kost J., and Langer R. Mechanistic studies of macromolecular drug release from macroporous polymers. I. Experiments and preliminary theory concerning completeness of drug release. J. Control. Release 8 3 (1989) 223-236
28. Saltzman W., and Langer R. Transport rates of proteins in porous materials with known microgeometry. Biophys. J. 55 1 (1989) 163-171
29. Johnson O.L., and Tracy M.A. Peptide and protein drug delivery. In: Mathiowitz E. (Ed). Encyclopedia of Controlled Drug Delivery (1999), Wiley, Toronto 816-833
30. Wright J., Chandrasekaran S.K., Gale R., and Swanson D. Model for the release of osmotically active agents from monolithic polymeric matrices. AIChE Symp. Ser. 77 206 (1981)
31. Schirrer R., Thepin P., and Torres G. Water absorption, swelling, rupture and salt release in salt-silicone rubber compounds. J. Mater. Sci. 27 (1992) 3424-3434
32. Amsden B. A model for osmotic pressure driven release from cylindrical rubbery polymer matrices. J. Control. Release 93 (2003) 249-258
33. Amsden B., and Cheng Y.L. A generic protein delivery system based on osmotically rupturable monoliths. J. Control. Release 33 1 (1995) 99-105
34. Gu F., Neufeld R.J., and Amsden B. Osmotic driven release kinetics of bioactive therapeutic proteins from a biodegradable elastomer are linear, constant, similar and adjustable. Pharm. Res. 23 4 (2006) 782-789
35. Amsden B.G., and Cheng Y.L. Enhanced fraction releasable above percolation threshold from monoliths containing osmotic excipients. J. Control. Release 31 1 (1994) 21-32
36. Budavari S., O'Neil M., Smith A., Heckelman P.E., and Kinneary J.F. The Merck Index. 12th ed. (1996), Merck
37. Miller D.P., de Pablo J.J., and Corti H. Thermophysical properties of trehalose and its concentrated aqueous solutions. Pharm. Res. 14 5 (1997) 578-590